Fisher & Paykel Healthcare (NZSE:FPH) Total Inventories : NZ$360 Mil (As of Sep. 2023)

View and export this data going back to 1979. Start your Free Trial

What is Fisher & Paykel Healthcare Total Inventories?

Fisher & Paykel Healthcare's total inventories for the quarter that ended in Sep. 2023 was NZ$360 Mil. Fisher & Paykel Healthcare's average total inventories from the quarter that ended in Mar. 2023 to the quarter that ended in Sep. 2023 was NZ$363 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Fisher & Paykel Healthcare's Net-Net Working Capital per share for the quarter that ended in Sep. 2023 was NZ$-0.37.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Fisher & Paykel Healthcare's Days Inventory for the six months ended in Sep. 2023 was 208.56.

Inventory Turnover measures how fast the company turns over its inventory within a year. Fisher & Paykel Healthcare's Inventory Turnover for the quarter that ended in Sep. 2023 was 0.88.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Fisher & Paykel Healthcare's Inventory-to-Revenue for the quarter that ended in Sep. 2023 was 0.44.

Fisher & Paykel Healthcare Total Inventories Historical Data

The historical data trend for Fisher & Paykel Healthcare's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fisher & Paykel Healthcare Total Inventories Chart

Fisher & Paykel Healthcare Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Total Inventories

Get a 7-Day Free Trial

136.10

146.50

270.60

358.90

365.80

Fisher & Paykel Healthcare Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Total Inventories	Get a 7-Day Free Trial															291.80	358.90	398.40	365.80	360.10

Fisher & Paykel Healthcare Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Fisher & Paykel Healthcare (NZSE:FPH) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Fisher & Paykel Healthcare's Net-Net Working Capital Per Share for the quarter that ended in Sep. 2023 is

	Net-Net Working Capital Per Share (Q: Sep. 2023 )
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(70.5	+	0.75 * 233.2	+	0.5 * 360.1	-	638
-	0	-	0)	/	582.013
=	-0.37

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Fisher & Paykel Healthcare's Days Inventory for the six months ended in Sep. 2023 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Sep. 2023 )	/	Cost of Goods Sold (Q: Sep. 2023 )	*	Days in Period
	=	362.95	/	317.6	*	365 / 2
	=	208.56

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Fisher & Paykel Healthcare's Inventory Turnover for the quarter that ended in Sep. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Sep. 2023 )	/	Average Total Inventories (Q: Sep. 2023 )
	=	317.6	/	362.95
	=	0.88

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Fisher & Paykel Healthcare's Inventory to Revenue for the quarter that ended in Sep. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Sep. 2023 )	/	Revenue (Q: Sep. 2023 )
	=	362.95	/	815.8
	=	0.44

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

Fisher & Paykel Healthcare Total Inventories Related Terms

Thank you for viewing the detailed overview of Fisher & Paykel Healthcare's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.

Fisher & Paykel Healthcare (NZSE:FPH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Fisher & Paykel Healthcare Corp Ltd (NZSE:FPH) » Definitions » Total Inventories

Comparable Companies

Traded in Other Exchanges

FSPKF:USA FPLB:Germany FPH:Australia

Address

15 Maurice Paykel Place, East Tamaki, Auckland, NTL, NZL, 2013

Website

https://www.fphcare.com

Fisher & Paykel Healthcare is one of the three largest respiratory care device companies globally. It is the market leader in hospital use humidifiers, masks and related consumables and the number three player in the at-home treatment of sleep apnoea using respiratory devices. Both the hospital and homecare markets for respiratory devices are growing strongly in the developed markets in which Fisher & Paykel has a presence. The company earns 42% of its revenue in the U.S., 32% in Europe, 18% in Asia-Pacific and the remaining 8% in emerging markets. Fisher conducts its own R&D and has thousands of patents and pending applications. It manufactures in New Zealand and Mexico and has a multichannel distribution model.